Pharnext Valuation
| ALPHA Stock | EUR 0.0002 0.00 0.00% |
Pharnext seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Pharnext SA from analyzing the company fundamentals such as Shares Owned By Insiders of 0.68 %, current valuation of 20.06 M, and Return On Equity of -13.48 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Pharnext's price fluctuation is very steady at this time. Calculation of the real value of Pharnext SA is based on 3 months time horizon. Increasing Pharnext's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Pharnext's intrinsic value may or may not be the same as its current market price of 0.0002, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.68E-4 | Hype 2.0E-4 |
The intrinsic value of Pharnext's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pharnext's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pharnext SA helps investors to forecast how Pharnext stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharnext more accurately as focusing exclusively on Pharnext's fundamentals will not take into account other important factors: Pharnext Total Value Analysis
Pharnext SA is presently projected to have takeover price of 20.06 M with market capitalization of 680.75 K, debt of 13.2 M, and cash on hands of 18.17 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Pharnext fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
20.06 M | 680.75 K | 13.2 M | 18.17 M |
Pharnext Investor Information
The company recorded a loss per share of 4500.0. Pharnext SA had not issued any dividends in recent years. The entity had 10000:1 split on the 15th of February 2024. Based on the key indicators related to Pharnext's liquidity, profitability, solvency, and operating efficiency, Pharnext SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Pharnext Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pharnext has an asset utilization ratio of 0.52 percent. This connotes that the Company is making €0.005154 for each dollar of assets. An increasing asset utilization means that Pharnext SA is more efficient with each dollar of assets it utilizes for everyday operations.Pharnext Ownership Allocation
Pharnext owns a total of 875.25 Million outstanding shares. Roughly 99.28 pct. of Pharnext outstanding shares are held by general public with 0.68 % owned by insiders and only 0.04 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Pharnext Profitability Analysis
The company reported the revenue of 84.78 K. Net Loss for the year was (30.62 M) with profit before overhead, payroll, taxes, and interest of 3.56 M.About Pharnext Valuation
The stock valuation mechanism determines Pharnext's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Pharnext SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pharnext. We calculate exposure to Pharnext's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharnext's related companies.Pharnext SA, a clinical-stage biopharmaceutical company, develops therapeutics for severe orphan and common neurodegenerative diseases in France. The company was founded in 2007 and is based in Issy-Les-Moulineaux, France. Pharnext S is traded on Paris Stock Exchange in France.
8 Steps to conduct Pharnext's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Pharnext's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Pharnext's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Pharnext's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Pharnext's revenue streams: Identify Pharnext's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Pharnext's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Pharnext's growth potential: Evaluate Pharnext's management, business model, and growth potential.
- Determine Pharnext's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Pharnext's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Pharnext Stock Analysis
When running Pharnext's price analysis, check to measure Pharnext's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharnext is operating at the current time. Most of Pharnext's value examination focuses on studying past and present price action to predict the probability of Pharnext's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharnext's price. Additionally, you may evaluate how the addition of Pharnext to your portfolios can decrease your overall portfolio volatility.